C-Protein in Fatigue and Aging
University of Oregon · with Wu Tsai Human Performance Alliance, National Institutes of Health (NIH) · NCT05926219
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 24
- US sites recruiting
- 1
- Study start
- November 6, 2017
- Record last updated
- September 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is investigating changes to the proteins in skeletal muscle that contribute to reduced muscle size and muscle function that occurs with aging.
Being studied: Fatiguing Exercise
Conditions: Aging; Muscle Atrophy or Weakness; Sarcopenia in Elderly; Sarcopenia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults between the ages 18-35 or 65-80 years
- Healthy by self-report
- Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring
- Fluent in English (due to lack of translation services, it is not practical to conduct the study using a language other than English).
Exclusion Criteria
- Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.).
- Volunteer has dementia or related mental issues that potentially put the subject at risk as determined by prior diagnosis.
- Volunteer has known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease or Cushing's syndrome, etc.)
- Volunteer has untreated/poorly-controlled hypertension (stage 2, per American College of Cardiology [>140/90 mmHg]).
- Volunteer has significant heart, liver, kidney or respiratory disease.
- Volunteer has diabetes (insulin dependent or non-insulin dependent).
- Volunteer has known coagulopathies.
- Volunteer has taken anabolic steroids in the prior six months.
- Volunteer has received treatment for cancer (other than effective Mohs Surgery for successful removal of basal cell or squamous cell carcinomas)
- Unexpected weight loss >5kg is last 12 months
- Volunteer is an active smoker or quit within the last year.
- Volunteer has known current alcohol or drug use disorder (AUD; defined as binge drinking of >4 days in the last month. Binge drinking is >5 drinks for men and >4 drinks for women, per occasion). Or, if a volunteer reports drinking in excess of "low risk" per NIAAA (>7 drinks/week for men and >3 drinks/day for women and >14 drinks/week and >4 drinks/day).
- Volunteer has a diagnosed neuromuscular disorder.
- Volunteer has allergy to lidocaine.
Recruiting US locations
University of Oregon
Eugene, OR 97403
Site contact: Damien M Callahan, Ph.D. · 458-205-5343 · damienc@uoregon.edu
Study contacts (from the official record)
- Damien M Callahan, Ph.D. · 541-346-5040 · damienc@uoregon.edu
- Karen Wiedenfeld Needham, BS · 541-346-7610 · needham@uoregon.edu
Similar studies in Oregon
All healthy volunteers studies in Oregon →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Bend, OR + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 20–49
- RecruitingHealthy volunteersEarly Phase 1
Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 18–65 · Women only
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Portland, OR + 55 other US sites
- Eligibility basics
- Ages 18–79